GlassScriptPhysician profile
Patricia Bell
NPI 1619910551
$82,148.21
in general payments reported to CMS, 2019-2025
11 companies · $50.34 in 2025
The $50.34 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,659 · 2020: $2,056 · 2021: $21K · 2022: $13K · 2023: $35K · 2024: $9,536 · 2025: $50.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Travel and Lodging: $4,812 · Food and Beverage: $1,309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,775.00 |
| Travel and Lodging | $4,811.62 |
| Food and Beverage | $1,308.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $81,721.33 | 2019-2024 | Scopis Ent, Clarifix Cryotherapy Device, Latera |
| Glaxosmithkline, LLC. | $147.37 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $99.47 | 2021-2024 | Dupixent |
| Ars Pharmaceuticals Operations, INC. | $50.34 | 2025 | Neffy |
| Kaleo, INC. | $45.15 | 2020 | |
| Intersect Ent, INC. | $17.55 | 2019 | |
| Uswm, LLC | $17.00 | 2021 | |
| Optinose US, INC. | $15.55 | 2024 | |
| Merck Sharp & Dohme LLC | $12.24 | 2022 | |
| Smith+Nephew, INC. | $11.92 | 2019 | |
| Ambu INC. | $10.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.